Golden State Equity Partners Novo Nordisk A S Transaction History
Golden State Equity Partners
- $402 Million
- Q4 2023
A detailed history of Golden State Equity Partners transactions in Novo Nordisk A S stock. As of the latest transaction made, Golden State Equity Partners holds 3,544 shares of NVO stock, worth $471,989. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,544
Previous 3,521
0.65%
Holding current value
$471,989
Previous $320,000
14.37%
% of portfolio
0.09%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,891Shares Held
310MCall Options Held
5.36MPut Options Held
4.95M-
Jennison Associates LLC21.1MShares$2.81 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.83 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.74 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.6 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.57 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $301B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...